Xiaohong K. Xie

State Key Laboratory Of Respiratory Disease
Guangzhou, 510160, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Hypoxic Niche as an Early Determinant of EGFR-Mutant Lung Cancer Progression: Implications for Detection, Intervention, and Subtype-Specific Responses.

Hypoxic Niche as an Early Determinant of EGFR-Mutant Lung Cancer Progression: Implications for Detection, Intervention, and Subtype-Specific Responses.

Journal: American journal of respiratory and critical care medicine

Published: May 18, 2026

International Consensus on Severe Lung Cancer-The Second Edition.

International Consensus on Severe Lung Cancer-The Second Edition.

Journal: Translational lung cancer research

Published: March 21, 2026

Personalized treatment of HER2-positive lung adenocarcinoma using Human Organoid Drug Sensitivity Test.

Personalized treatment of HER2-positive lung adenocarcinoma using Human Organoid Drug Sensitivity Test.

Journal: Human vaccines & immunotherapeutics

Published: February 17, 2026

Toward Precision Implementation of Mind-Body Medicine in Oncology: Insights From the "Mind-Body Medicine Group Program for Cancer Patients".

Toward Precision Implementation of Mind-Body Medicine in Oncology: Insights From the "Mind-Body Medicine Group Program for Cancer Patients".

Journal: Integrative cancer therapies

Published: December 21, 2025

Development and external validation of a multivariable nomogram for predicting severe immune checkpoint inhibitor-associated myocarditis in advanced lung cancer.

Development and external validation of a multivariable nomogram for predicting severe immune checkpoint inhibitor-associated myocarditis in advanced lung cancer.

Journal: Translational lung cancer research

Published: November 18, 2025

Novel circulating microRNA signature for early detection and prognostication of checkpoint inhibitor-related pneumonitis.

Novel circulating microRNA signature for early detection and prognostication of checkpoint inhibitor-related pneumonitis.

Journal: Journal for immunotherapy of cancer

Published: August 26, 2025

Real-world single-center data analysis of dual immunotherapy in advanced NSCLC: Efficacy, survival, and adverse events.

Real-world single-center data analysis of dual immunotherapy in advanced NSCLC: Efficacy, survival, and adverse events.

Journal: Human vaccines & immunotherapeutics

Published: August 04, 2025

Mid-term analysis of a randomized controlled clinical trial on different transfusion strategies for cardiac valve surgery

Mid-term analysis of a randomized controlled clinical trial on different transfusion strategies for cardiac valve surgery

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: May 26, 2025

A public data-based molecular classification of small cell lung cancer by neuroactive signaling networks unveils distinct microenvironment landscapes and immunotherapy-related prognostic biomarkers.

A public data-based molecular classification of small cell lung cancer by neuroactive signaling networks unveils distinct microenvironment landscapes and immunotherapy-related prognostic biomarkers.

Journal: Translational lung cancer research

Published: May 24, 2025

Night shift work and lung cancer risk: a prospective cohort study with mediator analysis from the UK Biobank.

Night shift work and lung cancer risk: a prospective cohort study with mediator analysis from the UK Biobank.

Journal: Sleep

Published: March 18, 2025

Bronchial washing fluid supernatant serves as a novel liquid biopsy specimen for genome profiling in advanced non-small cell lung cancer.

Bronchial washing fluid supernatant serves as a novel liquid biopsy specimen for genome profiling in advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 17, 2025

Sintilimab plus chemotherapy for first-line treatment of advanced pulmonary lymphoepithelioma-like carcinoma: Phase 2 trial.

Sintilimab plus chemotherapy for first-line treatment of advanced pulmonary lymphoepithelioma-like carcinoma: Phase 2 trial.

Journal: Cell reports. Medicine

Published: February 16, 2025

Showing 1-12 of 75

Last Updated: 09/26/2026